Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors

本发明公开用作HIV逆转录酶抑制剂的苯并�嗪酮化合物的适口口服液体药用组合物，它包含在含有中链脂肪酸甘油三酯的液体载体中的所述苯并�嗪酮活性成分。可任选加入其它的制剂试剂例如甜味剂、卵磷脂悬浮剂等。 A palatable oral liquid pharmaceutical composition of benzoxazinone compounds useful as HIV reverse transcriptase inhibitors comprising the benzoxazinone active ingredient in a liquid vehicle comprising medium chain fatty acid triglycerides. Other formulating agents such as sweetening agents, lecithin suspending agents, etc. may be optionally added.